[1] |
CHATURVEDI A K, ENGELS E A, PFEIFFER R M, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States[J]. J Clin Oncol, 2011, 29(32): 4294-4301.
doi: 10.1200/JCO.2011.36.4596
|
[2] |
D’SOUZA G, KREIMER A R, VISCIDI R, et al. Case-control study of human papillomavirus and oropharyngeal cancer[J]. N Engl J Med, 2007, 356(19): 1944-1956.
doi: 10.1056/NEJMoa065497
|
[3] |
TERMINE N, PANZARELLA V, FALASCHINI S, et al. HPV in oral squamous cell carcinoma vs head and neck squamous cell carcinoma biopsies: a meta-analysis (1988-2007)[J]. Ann Oncol, 2008, 19(10): 1681-1690.
doi: 10.1093/annonc/mdn372
|
[4] |
ADELSTEIN D J, RIDGE J A, GILLISON M L, et al. Head and neck squamous cell cancer and the human papillomavirus: summary of a National Cancer Institute State of the Science Meeting, November 9-10, 2008, Washington, D.C[J]. Head Neck, 2009, 31(11): 1393-1422.
doi: 10.1002/hed.v31:11
|
[5] |
STURGIS E M, CINCIRIPINI P M. Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers?[J]. Cancer, 2007, 110(7): 1429-1435.
doi: 10.1002/(ISSN)1097-0142
|
[6] |
GILLISON M L, KOCH W M, CAPONE R B, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers[J]. J Natl Cancer Inst, 2000, 92(9): 709-720.
doi: 10.1093/jnci/92.9.709
|
[7] |
EL-NAGGAR A K, CHAN J K C, GRANDIS J R, et al. WHO classification of head and neck tumours[M]. Lyon: IARC, 2017.
|
[8] |
AMIN M B, EDGE S B, GREENE F L, et al. AJCC Cancer Staging Manual, 8th ed[M]. New York: Springer, 2017.
|
[9] |
EDGE S B, BYRD D R, COMPTON C C, et al. AJCC Cancer Staging Manual,7th ed[M]. New York: Springer, 2010.
|
[10] |
LAM E W, CHAN J Y, CHAN A B, et al. Prevalence, clinicopathological characteristics, and outcome of human papillomavirus-associated oropharyngeal cancer in southern Chinese patients[J]. Cancer Epidemiol Biomarkers Prev, 2016, 25(1): 165-173.
doi: 10.1158/1055-9965.EPI-15-0869
|
[11] |
ANG K K, HARRIS J, WHEELER R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer[J]. N Engl J Med, 2010, 363(1): 24-35.
doi: 10.1056/NEJMoa0912217
|
[12] |
CIANCHETTI M, MANCUSO A A, AMDUR R J, et al. Diagnostic evaluation of squamous cell carcinoma metastatic to cervical lymph nodes from an unknown head and neck primary site[J]. Laryngoscope, 2009, 119(12): 2348-2354.
doi: 10.1002/lary.20638
|
[13] |
GOLDENBERG D, BEGUM S, WESTRA W H, et al. Cystic lymph node metastasis in patients with head and neck cancer: an HPV-associated phenomenon[J]. Head Neck, 2008, 30(7): 898-903.
doi: 10.1002/(ISSN)1097-0347
|
[14] |
CHERNOCK R D, EL-MOFTY S K, THORSTAD W L, et al. HPV-related nonkeratinizing squamous cell carcinoma of the oropharynx: utility of microscopic features in predicting patient outcome[J]. Head Neck Pathol, 2009, 3(3): 186-194.
doi: 10.1007/s12105-009-0126-1
|
[15] |
FUJIMAKI M, FUKUMURA Y, MITANI K, et al. Histological subtypes and characteristic structures of HPV-associated oropharyngeal carcinoma: study with Japanese cases[J]. Diagn Pathol, 2013, 8: 211.
doi: 10.1186/1746-1596-8-211
|
[16] |
ZHAO Y H, BAI Y P, MAO M L, et al. Clinicopathological characteristics of HPV(+) oropharyngeal squamous cell carcinoma[J]. Chin J Pathol, 2019, 48(2): 127-131.
|
[17] |
SINGHI A D, STELOW E B, MILLS S E, et al. Lymphoepithelial-like carcinoma of the oropharynx: a morphologic variant of HPV-related head and neck carcinoma[J]. Am J Surg Pathol, 2010, 34(6): 800-805.
doi: 10.1097/PAS.0b013e3181d9ba21
|
[18] |
DAMATO S, THAVARAJ S, WINTER S, et al. Human papillomavirus-associated adenocarcinoma of the palatine tonsil[J]. Hum Pathol, 2014, 45(4): 893-894.
doi: 10.1016/j.humpath.2013.09.023
|
[19] |
KRAFT S, FAQUIN W C, KRANE J F. HPV-associated neuroendocrine carcinoma of the oropharynx: a rare new entity with potentially aggressive clinical behavior[J]. Am J Surg Pathol, 2012, 36(3): 321-330.
doi: 10.1097/PAS.0b013e31823f2f17
|
[20] |
MAXWELL J H, KUMAR B, FENG F Y, et al. HPV-positive/p16-positive/EBV-negative nasopharyngeal carcinoma in white North Americans[J]. Head Neck, 2010, 32(5): 562-567.
|
[21] |
POLZ-GRUSZKA D, MORSHED K, STEC A, et al. Prevalence of human papillomavirus (HPV) and Epstein-Barr virus (EBV) in oral and oropharyngeal squamous cell carcinoma in south-eastern Poland[J]. Infect Agent Cancer, 2015, 10: 37.
doi: 10.1186/s13027-015-0031-z
|
[22] |
FAKHRY C, WESTRA W H, LI S G, et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial[J]. J Natl Cancer Inst, 2008, 100(4): 261-269.
doi: 10.1093/jnci/djn011
|
[23] |
National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology. Head And Neck Cancer Version 3, 2021[EB/OL].[2021-04-27]. http://www.nccn.org .
|
[24] |
中国临床肿瘤学会指南工作委员会.中国临床肿瘤学会(CSCO)头颈部肿瘤诊疗指南(2021版)[M]. 北京: 人民卫生出版社, 2021.
|
|
Guidelines Working Committee of Chinese Society of Clinical Oncology. Head and Neck Cancer Guidelines of Chinese Society of Clinical Oncology (CSCO) (2021 ed)[M]. Beijing: People’s Medical Publishing House, 2021.
|